Lugol Solution

Quick links to important sections

Lugol Solution

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lugol Solution

Property Description
Active Ingredients Iodine, Potassium Iodide
Form Aqueous Solution (Liquid preparation)
Pharmacological Class Antiseptic/Disinfectant, Thyroid Agent
General Purpose Germicidal action and inorganic iodine supply
Origin Inorganic compound mixture

Classification and Identity of Compound Iodine Solution

Lugol Solution, formally known as Compound Iodine Solution or Lugol's Strong Iodine Solution in the USP, is an established liquid preparation that functions dually as both an Antiseptic/Disinfectant and a specialized Thyroid Agent. This transparent, deep-brown liquid is a historical preparation, with its formula being clinically recognized for over a century. A strong iodine solution is recognized as an essential medicine. This classification is particularly noteworthy, differentiating it from simple iodide salt supplements by its high iodine concentration designed for specific systemic effects. The preparation's versatility is a key feature, permitting use through both topical and oral routes for diverse patient needs.

Composition: The Combination of Iodine and Potassium Iodide

Lugol Solution is a combination product that contains two primary active ingredients: elemental Iodine (I2) and Potassium Iodide (an iodide salt), dissolved in a Purified water (aqueous base). This specific two-component composition ensures the stability and effective delivery of the active ingredients. For example, while many topical antiseptics use iodine derivatives, Lugol Solution provides the elemental Iodine directly, stabilized by the Potassium Iodide. This inorganic compound mixture provides a concentrated and stable supply of readily bioavailable inorganic iodine, an essential trace element critical for thyroid hormone synthesis and overall metabolic function.

Mechanism of Action and General Purpose

The general purpose of Lugol Solution is driven by its unique dual mechanism: potent external antimicrobial action and acute internal thyroid modulation. The elemental iodine component exerts germicidal action, functioning as a broad-spectrum bactericidal and virucidal agent, which makes it a common preparation for cleansing minor wounds or skin abrasions. Internally, the high concentration of the iodide salt acts as a temporary thyroid-blocking agent by acutely inhibiting the synthesis and release of thyroid hormones within the gland. The dual functionality is what provides this aqueous solution its broad utility, enabling both its surface disinfection and systemic thyroid-modulating properties.

Regulatory References

  1. WHO Electronic Essential Medicines List (Lugol's solution)
  2. Potassium Iodide: MedlinePlus Drug Information
  3. Potassium Iodide

What side effects are possible with Lugol Solution?

Possible side effects and safety information

The officially documented adverse effects of Compound Iodine Solution (Lugol Solution) are generally categorized by the physiological system affected and by exposure duration, as outlined in government regulatory documents.


Adverse Reactions and Systemic Effects

Adverse reactions are documented across several System-Organ Classes (SOC) and are often classified with a Frequency Not Known, meaning exact statistical rates cannot be determined from available data, which is typical for older medicinal preparations.

System-Organ Class (SOC) Examples of Officially Documented Effects
Gastrointestinal Metallic taste, vomiting, stomach pain, increased salivation, or diarrhea.
Skin & Subcutaneous Rash, itching (pruritus), and acneiform skin eruptions.
Endocrine System Thyroid gland enlargement (Goitre) and thyrotoxicosis (iodine-induced hyperthyroidism).

Serious adverse reactions listed in regulatory sources include severe Hypersensitivity Reactions (such as angioedema and fever) and the development of Iodine-induced Hyperthyroidism. Ingestion of excessive quantities is associated with signs of acute poisoning, including corrosive gastrointestinal effects.


Duration-Related Patterns and Safety Constraints

The safety profile distinguishes effects based on duration of exposure. Symptoms of chronic iodine intoxication, known as Iodism, are associated with long-term use and may include headache, runny nose, and pain in the salivary glands. The solution is not intended for long-term treatment.

Official regulatory documents place specific constraints on use in certain groups. The solution is contraindicated in patients with a known hypersensitivity to iodine or iodides. Furthermore, it should not be used during pregnancy or lactation due to the potential risk of goitre and hypothyroidism in the fetus or infant. Caution is noted for the elderly and individuals with pre-existing thyroid disease, as they may be at an increased risk of developing thyrotoxicosis.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines information regarding Lugol Solution (Strong Iodine Solution) overdose and emergency actions, based on authoritative health and regulatory documents.

Overdose Presentations and Risk

Ingestion of large quantities of Lugol Solution may lead to iodine poisoning. The documented clinical manifestations associated with such exposure primarily affect the gastrointestinal system and can include abdominal pain, nausea, vomiting, and diarrhea.

Regulatory warnings indicate that a high-volume intake of the solution, where the total free iodine content exceeds several grams, is associated with the risk of severe toxicity. Furthermore, the iodine component readily crosses the placental barrier, which may pose a risk to the fetus if accidental overdose occurs during pregnancy.

Required Emergency Action

Immediate medical attention is required in the event of any accidental overdose.

Action Required
Seek professional assistance or contact a Poison Control Center immediately.
If the solution has been swallowed, call a physician.
Do not induce vomiting.

It is essential to contact emergency services or a poison control center right away to receive guidance on the next steps following any suspected ingestion beyond the recommended use.

Therapeutic Uses of Lugol Solution

What Lugol Solution Treats: Main Uses and Benefits

Lugol Solution (iodine/potassium iodide) is generally used to help manage symptoms related to specific thyroid conditions and to support iodine balance in the body, which is applied in clinical settings that involve acute or unstable symptom patterns.


This solution is commonly used to help with conditions where functional stability becomes affected due to insufficient iodine, such as simple goiter, and is considered relevant for easing symptoms associated with heightened physiological activity, such as in hyperthyroidism. The solution is used in the pre-operative management of hyperthyroidism and for thyroid protection in radiation emergencies. This application helps maintain a sense of stability and supports general well-being during symptomatic phases.

In therapeutic use, it may assist with stabilizing the patient and helps address symptom clusters that may become intense or disruptive before definitive treatment. The primary therapeutic uses include the supportive management of thyroid overactivity and addressing iodine deficiency.

“The solution is applied in contexts marked by temporary physiological imbalance during nuclear events.”

Quick Fact: Supportive Use for Heightened Symptoms
This solution is relevant when short-term symptomatic assistance is needed to assist with discomfort and functional strain during periods of acute symptoms.

This is applied across domains where additional symptomatic support is needed to provide supportive relief and contributes to easing the overall symptom load.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lugol Solution?

The eligibility for Strong Iodine Solution (Lugol Solution) is strictly defined by regulatory contraindications and required cautions documented in official government prescribing information. Use is primarily established for adults and teenagers undergoing specific thyroid treatments who do not have any listed non-eligibility conditions.


Populations Prohibited from Use (Contraindicated)

Category Non-Eligibility Statement
Allergy/Hypersensitivity Contraindicated in patients with a known sensitivity to iodides or iodine or with iododerma (Source 2.3).
Comorbidity Contraindicated in patients with active Tuberculosis (Source 1.5).
Prior Reactions Contraindicated following prior reactions such as laryngeal edema or swelling of salivary glands (Source 2.3).

Populations Requiring Restricted or Conditional Use

Category Regulatory Status
Pregnancy Restricted; the drug readily crosses the placental barrier and may affect the fetus (Source 2.3).
Lactation Restricted; passes into breast milk and may lead to low thyroid hormone levels in the baby (Source 2.6).
Pediatric Use Conditional; use requires physician-determined dosage, as it may cause thyroid problems in infants (Source 1.3).

Regulatory restrictions also mandate caution in patients with pre-existing kidney disease or bronchitis, and prolonged therapy is restricted due to the risk of iodism (Source 1.3, 2.3).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lugol Solution contains iodide, which can be involved in clinically significant interactions by affecting drug concentrations and physiological function. These interactions are derived strictly from official government regulatory documents.

Pharmacodynamic and Physiologic Interactions

The iodide component significantly interferes with the thyroid's uptake of radioactive iodine (Sodium Iodide I-131). This interference necessitates a mandated withdrawal period of the solution before diagnostic or therapeutic use of radioiodine. Concomitant use with antithyroid medications (e.g., thionamides) may lead to additive pharmacodynamic effects, increasing the risk of hypothyroidism.

Pharmacokinetic and Exposure-Based Interactions

Due to its potassium content, co-administration with drugs that raise serum potassium levels, such as potassium-sparing diuretics (e.g., amiloride, spironolactone) and Angiotensin-Converting Enzyme (ACE) inhibitors, may increase the risk of hyperkalemia. Furthermore, the iodide component can bind to certain orally administered drugs in the gastrointestinal tract, potentially decreasing the absorption of products like tetracyclines and baloxavir marboxil.

Population and Procedural Constraints

The administration of the solution may be constrained by procedural requirements, such as the mandated separation from radioiodine therapy. The official labels also note that iodine passes into breast milk and may affect the breastfed infant, requiring specific monitoring or cessation of breastfeeding during treatment.

Mechanism of Action

Acute Blockade of Thyroid Hormone Release

The primary systemic action involves the high concentration of the iodide ion ( I^-) acutely inhibiting the Thyroid Peroxidase (TPO) enzyme and thyroglobulin proteases. This mechanism, known as the Wolff-Chaikoff effect, rapidly and simultaneously blocks the synthesis of new T3/ T4 and suppresses the release of hormones already stored in the gland. This action produces the core physiological consequence of reducing circulating thyroid hormone concentrations, which contributes to a temporary adjustment in metabolic signaling.

Modulation of Thyroid Gland Vascular Tone

A second concentration-dependent mechanism is exerted locally on the thyroid tissue, where sustained high Iodide concentration affects the local signaling that regulates blood vessel diameter and density. This process leads to localized vasoconstriction and tissue-level changes, resulting in reduced gland vascularity and increased tissue consistency. This physiological adjustment is achieved by limiting blood flow and influencing tissue consistency.

Non-Specific Oxidative Germicidal Action

The action of elemental iodine ( I2) is purely chemical and local. It functions as a powerful oxidizing agent, immediately reacting with and causing the denaturation of essential proteins in bacteria and viruses by targeting specific residues like cysteine ( -SH) groups. This non-selective chemical disruption leads to the rapid inactivation and destruction of microbial cellular components upon contact, resulting in broad-spectrum microbial inactivation.

Dosage and Administration Information

How to Use Lugol Solution

Compound Iodine Solution, also known as Strong Iodine Solution, is administered using distinct patterns based on whether it is used systemically or topically.


Established Administration Guidelines

Scope Item Instruction Detail
Route of Administration The preparation is used for oral intake for systemic effect and topical application as a local anti-infective agent.
Standard Dosing Regimen For pre-operative management of hyperthyroidism, the standard oral dose is 0.1 mL to 0.3 mL per administration. This dosage is applied for adults, the elderly, and children.
Frequency and Schedule The oral dose is administered three times daily (TID).
Preparation Requirement The measured dose is diluted in a full glass of water or milk before being consumed immediately to aid administration and tolerability.
Course Duration The solution is intended exclusively for short-term use and is not used for long-term treatment. The treatment course typically lasts six to ten days immediately prior to a definitive procedure.

Procedural Structure

Established protocols define a strict, time-bound framework for systemic use. This framework necessitates the accurate measurement of the small volume (0.1 mL to 0.3 mL) using a calibrated device before the dose is diluted and consumed three times daily. This short-term procedural structure governs the standardized administration of the solution.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lugol Solution


Evidence for Pre-operative Management of Hyperthyroidism

Lugol Solution was studied for its role in the examination of symptom patterns and thyroid gland stabilization in patients who are preparing for surgery. Research has been conducted in people with conditions like Graves' disease or toxic nodular goiter. These investigations, which include pharmacological studies and analyses of observational cohorts, explored how symptoms change over time during the period leading up to the operation.

Studies examined several key factors, including changes in thyroid hormone levels and measurements related to systemic or functional imbalance. The findings describe patterns observed in the studies related to pre-operative stability, providing context on how symptoms were monitored in the observed populations during this short-term preparatory phase.

Long-term outcomes are not well characterized. Because the preparation is primarily applied in research contexts involving fluctuating or unstable symptoms right before surgery, follow-up durations were limited.


Evidence for Thyroid Protection in Radiation Emergencies

Lugol Solution was evaluated in emergency scenarios involving radiation exposure. The scientific context was explored through pharmacological studies and analyses used by regulatory bodies like the MHRA and FDA. This research explored the protective mechanism, which was studied for its role in preventing the thyroid gland from absorbing radioactive iodine.

Studies in this field did not look for long-term therapeutic effects but rather focused on episodes where symptoms become more noticeable due to external factors. The core research examined the parameters that were monitored to saturate the thyroid gland, which was observed in this type of protection. These findings indicate the product's relevance in contexts involving a temporary physiological imbalance during nuclear events.

What remains uncertain is the relevance of this protection beyond radioactive iodine exposure; the scope of the evidence is limited to this specific protective action.


Evidence for Supportive Use in Simple Goiter and Iodine Deficiency

Lugol Solution was studied for its role in the supportive management of conditions related to insufficient iodine supply, such as simple goiter. This evidence is largely historical and includes pharmacological studies alongside clinical recognition of the preparation’s use. Research examined how the product might address functional stability affected by a lack of the essential trace element, iodine.

Frequently Asked Questions (FAQ)

Common questions about Lugol Solution (FAQ)


Q: What are the inactive ingredients in Lugol Solution?

A: In addition to the two active ingredients (Iodine and Potassium Iodide), official regulatory labeling for the solution indicates that the only inactive ingredient is purified water. This aqueous base is used to dissolve and stabilize the active components.


Q: Is Lugol Solution considered an over-the-counter medicine?

A: For its established systemic uses, Strong Iodine Solution is classified as a Prescription Only Medicine (or Legend Drug) in many regions, including the United States. While some unapproved or topical formulations may be available over-the-counter, the official version for internal treatment is typically classified as a prescription-only medicine.


Q: How quickly does Lugol Solution start to have an effect?

A: Official pharmacological descriptions indicate that the solution's action is designed to be rapid and acute. It works quickly to inhibit the release of thyroid hormones, and clinical effects are noted during the short-term preparation phase before a procedure.


Q: Are there any long-term safety concerns with using Lugol Solution?

A: Yes, official safety information states that the solution is not intended for long-term treatment. Prolonged use is associated with a risk of developing chronic iodine intoxication, referred to as Iodism. Symptoms of this chronic state may include a metallic taste, headache, and acne-like skin eruptions.


Q: What should I do if I miss a planned administration of Lugol Solution?

A: Official guidance from regulatory sources suggests taking the dose as soon as the individual remembers it. If it is almost time for the next scheduled dose, regulatory guidance suggests the missed dose should be skipped entirely. Doses should not be doubled to compensate for a missed one, and the individual should return to their regular schedule.


Q: Is it normal for Lugol Solution to have a specific taste or smell?

A: Yes, the solution has a characteristic odor associated with iodine. Official regulatory documents list a metallic taste as a commonly reported adverse reaction or symptom related to the medication.


Q: Can Lugol Solution be taken with food, or does it need to be on an empty stomach?

A: Official administration guidance frequently suggests taking the measured dose diluted in milk, juice, or water. Diluting the dose and taking it with food is often suggested to support tolerability.


Q: Is Lugol Solution used for radiation exposure protection?

A: Yes, the potassium iodide component of the solution is studied for its role in emergency scenarios involving radiation exposure. The solution is studied for its role in rapidly saturating the thyroid gland with non-radioactive iodine to help limit the uptake of radioactive iodine.


Q: Can pregnant individuals use Lugol Solution?

A: The use of the solution during pregnancy is restricted according to regulatory warnings. This is because the iodide component readily crosses the placental barrier and may lead to serious thyroid issues, such as goiter or low thyroid hormone levels, in the developing fetus.


Q: Are there warnings about using Lugol Solution while breastfeeding?

A: Yes, use during lactation is restricted because iodide passes into breast milk. Regulatory warnings note that this transfer may potentially lead to a skin rash or thyroid suppression in the breastfed infant.


Q: Can Lugol Solution interact with multivitamins or mineral supplements?

A: Official regulatory labels include a general warning that the iodide component can bind to certain orally administered substances in the gastrointestinal tract. The label warns that the iodide component can bind to certain orally administered substances, which may decrease their absorption.


Q: Are there any reported interactions between Lugol Solution and herbal supplements?

A: Official warnings note the importance of discussing all concomitant products, including herbal supplements, with a healthcare provider. This is because potential interactions with the components of the solution have been noted.


Q: Does taking Lugol Solution affect thyroid function test results?

A: Yes, regulatory documents indicate that the iodide component of the solution may interfere with and alter the results of certain standard thyroid function blood tests used for diagnostic purposes.


Q: Why does Lugol Solution contain potassium iodide?

A: The potassium iodide component serves two main roles. It helps to effectively dissolve and stabilize the elemental iodine in the water base, ensuring the solution remains concentrated. It also provides a ready source of the iodide ion for the acute therapeutic effects within the body.


Q: Does research support the use of Lugol Solution for conditions other than its primary indication?

A: Yes, regulatory and clinical summaries indicate that research evidence addresses more than just pre-operative use. Studies have also been conducted on its supportive role in managing simple goiter and its specific, time-critical use for acute radiation protection.


Q: How long do patients typically use Lugol Solution?

A: The solution is strictly intended for short-term use for its systemic indications, such as preparation for thyroid surgery. The typical duration of administration is commonly defined in regulatory guidelines as a short course, often lasting six to ten days.


Q: Does Lugol Solution stain clothing or materials?

A: Official safety information for the highly concentrated solution notes that the physical properties of the product, due to its iodine content, mean it may result in staining if it comes into contact with clothing or skin.


Q: Is the research evidence for Lugol Solution considered strong?

A: As a historical preparation, the solution's evidence base is often described in regulatory summaries. Evidence supporting its systemic use focuses on specific, short-term procedural contexts, such as pre-operative stabilization and acute protection.


Q: Does Lugol Solution require a prescription in all regions?

A: The regulatory status of Lugol Solution can vary globally. However, for its established systemic uses, regulatory authorities in major regions frequently classify it as a prescription-only medicine (POM) due to its potency and potential for systemic effects.


Q: Does the color of Lugol Solution indicate its strength or freshness?

A: The solution is naturally a deep brown color. Official patient information includes warnings that the solution is not to be used if it has turned a brownish-yellow color or if crystals have formed, as these changes may signal a change in the product's stability.


Q: How does the body eliminate the components of Lugol Solution?

A: Following oral administration, the iodide component is rapidly absorbed by the body. The primary way the body eliminates this component is through excretion by the kidneys into the urine. Smaller amounts are also known to be eliminated via saliva, sweat, and breast milk.


Q: Does Lugol Solution have an expiration date?

A: Yes, regulatory requirements mandate that all pharmaceutical products, including Lugol Solution, must have an expiration date clearly printed on the label by the manufacturer. The product is not to be used past this specified date.

How should Lugol Solution be stored and disposed of?

How to Store and Dispose of Lugol Solution

Lugol Solution (Strong Iodine Solution USP) must be stored strictly according to regulatory specifications to maintain stability. The product is required to be kept at controlled room temperature, specifically between 15 C and 30 C (59 F and 86 F). The container must be protected from light, kept tightly closed, and stored away from excessive heat or moisture. It is required that the solution be kept from freezing.

For safety, the medicine must be stored out of the sight and reach of children.

Disposal must adhere to strict regulatory guidelines. Unused or expired product, including opened containers and applicators, must be disposed of following local hazardous waste practices. Regulatory labeling prohibits subjecting this waste to any thermal process intended for destruction or recycling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lugol Solution found in:

A-Z Index: